Pembrolizumab in Patients with Refractory Cutaneous Squamous Cell Carcinoma: A Phase II Trial

被引：0
|
作者：
Renata Ferrarotto
Luana G. Sousa
Yun Qing
Diana Kaya
Bettzy Stephen
Dipti Jain
Diana Bell
Shubham Pant
Apostolia M. Tsimberidou
Filip Janku
George Blumenschein
Bonnie S. Glisson
Jordi Rodon Ahnert
Sarina A. Piha-Paul
J. Jack Lee
Michael K. Wong
Charles Lu
Funda Meric-Bernstam
Aung Naing
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Thoracic/Head and Neck Medical Oncology
[2] The University of Texas MD Anderson Cancer Center,Department of Biostatistics
[3] The University of Texas MD Anderson Cancer Center,Department of Radiology
[4] The University of Texas MD Anderson Cancer Center,Department of Investigational Cancer Therapeutics
[5] The University of Texas MD Anderson Cancer Center,Department of Pathology
来源：
Advances in Therapy | 2021年 / 38卷
关键词：
Pembrolizumab; Checkpoint inhibitor; Rare cancers; Cutaneous squamous cell carcinoma; Skin cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4581 / 4591
页数：10
相关论文
共 50 条
  • [41] Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
    Saba, Nabil F.
    Steuer, Conor E.
    Ekpenyong, Asari
    McCook-Veal, Ashley
    Magliocca, Kelly
    Patel, Mihir
    Schmitt, Nicole C.
    Stokes, William
    Bates, James E.
    Rudra, Soumon
    Remick, Jill
    McDonald, Mark
    Abousaud, Marin
    Tan, Aik Choon
    Fadlullah, Muhammad Zaki Hidayatullah
    Chaudhary, Ritu
    Muzaffar, Jameel
    Kirtane, Kedar
    Liu, Yuan
    Chen, Georgia Z.
    Shin, Dong M.
    Teng, Yong
    Chung, Christine H.
    NATURE MEDICINE, 2023, 29 (04) : 880 - 887
  • [42] Preoperative pembrolizumab plus chemotherapy for resectable esophageal squamous cell carcinoma (ESCC): The phase II Keystone-001 trial
    Jiang, H.
    Shang, X.
    Xie, Y.
    Zhao, G.
    Zhang, C.
    Zhang, W.
    Liu, L.
    Li, R.
    Yue, J.
    Chen, C.
    Duan, X.
    Ma, Z.
    Sun, Y.
    Yu, J.
    Ren, X.
    ANNALS OF ONCOLOGY, 2023, 34 : S872 - S873
  • [43] A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with squamous cell carcinoma of the head and neck
    Taylor, Matthew H.
    Rasco, Drew W.
    Brose, Marcia S.
    Vogelzang, Nicholas J.
    Richey, Stephen L.
    Cohen, Allen L.
    Richards, Donald A.
    Stepan, Daniel E.
    Dutcus, Corina E.
    Guo, Matthew
    Shumaker, Robert C.
    Schmidt, Emmett V.
    Young, Louise
    Wirth, Lori J.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 174 - 174
  • [44] Phase II basket trial evaluating the efficacy of pembrolizumab (PE) combined with vorinostat (VO) in patients (pts) with recurrent and/or metastatic squamous cell carcinoma (SCC)
    Le Tourneau, Christophe
    Bigot, Frederic
    Vansteene, Damien
    Kamal, Maud
    Ghiringhelli, Francois
    Mazzarella, Luca
    Borel, Christian
    Chaltiel, Raphael
    You, Benoit
    Gomez-Roca, Carlos A.
    Cousin, Sophie
    Coquan, Elodie
    Lambert, Aure Prime Lien
    Saada-Bouzid, Esma
    Durando, Xavier
    Legrand, Francois
    Lusque, Amellie
    Andre, Fabrice
    Filleron, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [45] Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva
    Horowitz, N. S.
    Olawaiye, A. B.
    Borger, D. R.
    Growdon, W. B.
    Krasner, C. N.
    Matulonis, U. A.
    Liu, J. F.
    Lee, J.
    Brard, L.
    Dizon, D. S.
    GYNECOLOGIC ONCOLOGY, 2012, 127 (01) : 141 - 146
  • [46] Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma
    Conroy, T
    Etienne, PL
    Adenis, A
    Wagener, DJT
    Paillot, B
    Francois, E
    Bedenne, L
    Jacob, JH
    Seitz, JF
    Bleiberg, H
    VanPottelsberghe, C
    VanGlabbeke, M
    Delgado, FM
    Merle, S
    Wils, J
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) : 164 - 170
  • [47] PHASE-II TRIAL OF AMSA IN PATIENTS WITH REFRACTORY SMALL CELL-CARCINOMA OF THE LUNG
    FUKS, JZ
    VANECHO, DA
    AISNER, J
    VONHOFF, D
    WIERNIK, PH
    CANCER TREATMENT REPORTS, 1981, 65 (1-2): : 133 - 134
  • [48] Phase II trial of capecitabine in recurrent squamous cell carcinoma of the cervix
    Jenkins, AD
    Ramondetta, LM
    Sun, C
    Johnston, T
    Wolf, JK
    Bodurka, DC
    Brown, J
    Atkinson, EN
    Levenback, C
    GYNECOLOGIC ONCOLOGY, 2005, 97 (03) : 840 - 844
  • [49] A PHASE-II TRIAL OF VINDESINE IN PATIENTS WITH REFRACTORY SMALL-CELL CARCINOMA OF THE LUNG
    FUKS, JZ
    AISNER, J
    CARNEY, DN
    VANECHO, DA
    OSTROW, SS
    IHDE, DC
    WIERNIK, PH
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (01): : 49 - 52
  • [50] Phase Ib/II trial of Ibrutinib and Nivolumab in Patients with Advanced Refractory Renal Cell Carcinoma
    Parikh, Mamta
    Tenold, Matthew E.
    Qi, Lihong
    Lara, Frances
    Robles, Daniel
    Meyers, Frederick J.
    Lara, Primo N.
    KIDNEY CANCER, 2021, 5 (04) : 181 - 187
12345